Pharmadrug Valuation
| LMLLF Stock | USD 0.01 0.0005 4.63% |
Pharmadrug seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Pharmadrug from analyzing the company fundamentals such as Current Valuation of 4.43 M, return on equity of -0.59, and Shares Owned By Insiders of 1.88 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Pharmadrug's price fluctuation is out of control at this time. Calculation of the real value of Pharmadrug is based on 3 months time horizon. Increasing Pharmadrug's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pharmadrug pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Pharmadrug. Since Pharmadrug is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharmadrug Pink Sheet. However, Pharmadrug's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0103 | Real 0.009888 | Hype 0.01 | Naive 0.009269 |
The real value of Pharmadrug Pink Sheet, also known as its intrinsic value, is the underlying worth of Pharmadrug Company, which is reflected in its stock price. It is based on Pharmadrug's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pharmadrug's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pharmadrug helps investors to forecast how Pharmadrug pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharmadrug more accurately as focusing exclusively on Pharmadrug's fundamentals will not take into account other important factors: Pharmadrug Total Value Analysis
Pharmadrug is now expected to have takeover price of 4.43 M with market capitalization of 3.97 M, debt of 786.37 K, and cash on hands of 126.38 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Pharmadrug fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.43 M | 3.97 M | 786.37 K | 126.38 K |
Pharmadrug Investor Information
The company has price-to-book ratio of 0.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pharmadrug recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 2nd of August 2016. Based on the key indicators obtained from Pharmadrug's historical financial statements, Pharmadrug is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Pharmadrug Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Pharmadrug has an asset utilization ratio of 2.54 percent. This implies that the Company is making $0.0254 for each dollar of assets. An increasing asset utilization means that Pharmadrug is more efficient with each dollar of assets it utilizes for everyday operations.Pharmadrug Ownership Allocation
Pharmadrug owns a total of 355.63 Million outstanding shares. Roughly 98.12 pct. of Pharmadrug outstanding shares are held by general public with 1.88 % owned by insiders and only 0.0 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pharmadrug Profitability Analysis
The company reported the revenue of 494.99 K. Net Loss for the year was (5.63 M) with profit before overhead, payroll, taxes, and interest of 182.04 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pharmadrug's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pharmadrug and how it compares across the competition.
About Pharmadrug Valuation
The pink sheet valuation mechanism determines Pharmadrug's current worth on a weekly basis. Our valuation model uses a comparative analysis of Pharmadrug. We calculate exposure to Pharmadrug's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharmadrug's related companies.Pharmadrug Inc. operates as a specialty pharmaceutical company. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Pharmadrug's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Pharmadrug's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pharmadrug's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pharmadrug's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pharmadrug's revenue streams: Identify Pharmadrug's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pharmadrug's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pharmadrug's growth potential: Evaluate Pharmadrug's management, business model, and growth potential.
- Determine Pharmadrug's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pharmadrug's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pharmadrug Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pharmadrug does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 340.8 M | |
| Retained Earnings | -19.4 M |
Complementary Tools for Pharmadrug Pink Sheet analysis
When running Pharmadrug's price analysis, check to measure Pharmadrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmadrug is operating at the current time. Most of Pharmadrug's value examination focuses on studying past and present price action to predict the probability of Pharmadrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmadrug's price. Additionally, you may evaluate how the addition of Pharmadrug to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |